MOACM
BHVN

Mutual of America Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Mutual of America Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,959
Closed -$4.83M – 1638
2022
Q3 		$4.83M Sell
31,959
-2,907
-8% -$431K 0.07% 419
2022
Q2 		$5.08M Sell
34,866
-261
-0.7% -$33.3K 0.07% 436
2022
Q1 		$4.17M Sell
35,127
-14,884
-30% -$1.86M 0.04% 637
2021
Q4 		$6.89M Sell
50,011
-23,766
-32% -$3.02M 0.07% 388
2021
Q3 		$10.2M Sell
73,777
-1,063
-1% -$133K 0.1% 195
2021
Q2 		$7.26M Sell
74,840
-3,223
-4% -$262K 0.07% 337
2021
Q1 		$5.34M Buy
78,063
+34,603
+80% +$2.8M 0.06% 462
2020
Q4 		$3.73M Sell
43,460
-912
-2% -$77.3K 0.04% 620
2020
Q3 		$2.88M Sell
44,372
-7,592
-15% -$498K 0.04% 639
2020
Q2 		$3.8M Buy
51,964
+6,576
+14% +$350K 0.05% 486
2020
Q1 		$1.54M Sell
45,388
-1,996
-4% -$91.3K 0.03% 827
2019
Q4 		$2.58M Buy
+47,384
New +$2.35M 0.03% 804

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Mutual of America Capital Management's BHVN Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 31,959 shares — an estimated $4.83M sold.

Mutual of America Capital Management first reported a position in BHVN in Q4 2019 and held it in 12 quarters. The position peaked at $10.2M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 31,959 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.83M.
  • Mutual of America Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 12 quarters.
  • Mutual of America Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.2M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.